Breast cancer survivors (BCS) have significantly increased over the past 2 decades with over nine out of 10 patients living 5 years and beyond cancer diagnosis [ 1 ]. This improvement in survival rates has been accomplished thanks to significant …
Authors:
E. Mur-Gimeno, M. Coll, A. Yuguero-Ortiz, M. Navarro, M. Vernet-Tomás, A. Noguera-Llauradó, R. Sebio-García
Breast ADs are defined as a distortion of breast normal architecture without a definite visible mass according to the Breast Imaging Reporting and Data System (BI-RADS) lexicon [ 1 ]. The underlying cause of AD can be benign such as postoperative …
Authors:
Chiara Bellini, Francesca Pugliese, Giulia Bicchierai, Francesco Amato, Diego De Benedetto, Federica Di Naro, Cecilia Boeri, Ermanno Vanzi, Giuliano Migliaro, Ludovica Incardona, Cinzia Tommasi, Lorenzo Orzalesi, Vittorio Miele, Jacopo Nori
Open Access
27-05-2024 | Breast Cancer | Original Article
Breast cancer is the most frequently diagnosed malignancy and is currently considered the second most common death-related malignancy in females [ 1 ]. Previous statistical studies have shown that 266,120 women in the United States suffer from …
Authors:
Lizhi Teng, Juntong Du, Shuai Yan, Peng Xu, Jiangnan Liu, Xinyang Zhao, Weiyang Tao
Breast cancer ranks among the most prevalent malignancies globally, with an alarming surge in its incidence [ 1 ]. Predominantly, the therapeutic approach to breast cancer in India entails surgical intervention, primarily through modified radical …
Many clinical trials have shown that adjuvant endocrine therapy for hormone receptor-positive breast cancer (BC) reduces the risk of BC recurrence and mortality, and it is now standard practice to use this treatment continuously for 5–10 years [ 1 …
Authors:
Hiromi Okuyama, Fuka Takada, Naruto Taira, Seigo Nakamura
According to the Global Cancer Statistics report, breast cancer emerged as the prevailing form of cancer diagnosed in women, accounting for nearly 2.3 million new cases worldwide in 2020 [ 1 ]. Additionally, it ranked as the second major cause of …
Authors:
Beatriz Tinoco Franceschi, Patrícia Heloise Alves Bezerra, Maria Regina Torqueti
Triple-negative breast cancer (TNBC) is a heterogeneous disease which is immunohistochemically characterized by a lack of estrogen receptor (ER), progesterone receptor (PR), and a lack of human epidermal growth factor receptor 2 (HER2) …
Authors:
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, Agnès Basseville, Bertrand Michel, Jean-Sébastien Frenel, Philippe P. Juin, Fadoua Ben Azzouz, Mario Campone
Breast cancer continues to be the most prevalent cancer type among women. Due to the increasing incidence of breast cancer, advancements have been made in the treatment of the disease, leading to improvements in disease diagnosis and treatment …
Authors:
Songül Duran, Umut Varol, Özlem Tekir, Ahmet Hakan Soytürk
Breast cancer has become the most prevalent cancer among women, accounting for 11.7% of all global cancer cases [ 1 ]. This increase emphasizes the necessity for effective and efficient treatment strategies. The evolution of diagnostic and …
Authors:
Yong-qiang Bao, Teng-hua Yu, Wei Huang, Qing-feng Mao, Gan-jie Tu, Bin Li, An Yi, Jin-gao Li, Jun Rao, Huai-wen Zhang, Chun-ling Jiang
Open Access
29-04-2024 | Anthracycline | Original Article
Breast cancer is one of the most common malignancies in the world and the leading cause of cancer-related death among women [ 1 , 2 ]. Compared with other malignancies in Japanese women, breast cancer has the highest age-adjusted mortality rate …
Over the past two decades, the widespread adoption of screening mammography and advances in imaging have facilitated the detection of small early-stage breast tumors. This, alongside the successful demonstration of good local tumor control using …
Since the 1970s, tamoxifen has been one of the most effective and widely used anti-cancer drugs in patients with breast cancer [ 1 , 2 ]. Adjuvant tamoxifen therapy after primary surgical treatment markedly reduces the risk of recurrence of breast …
Authors:
Soo Jin Lee, Chihwan David Cha, Hanpyo Hong, Yun Young Choi, Min Sung Chung
Circulating tumor DNA (ctDNA) consists of DNA fragments released from cancer cells into the blood circulation with quick clearance. Analysis of ctDNA can enable real-time assessment of the presence of cancer cells and their genomic …
According to data from the World Health Organization (WHO) in 2020, there were about 2.3 million newly diagnosed breast cancer patients and 685,000 deaths from breast cancer in women worldwide. Breast cancer is a heterogeneous disease with …
Authors:
Pei-Jing Yang, Eing-Mei Tsai, Ming-Feng Hou, Yen-Jung Lee, Tsu-Nai Wang
Neoadjuvant or preoperative chemotherapy (NACT), defined as the administration of chemotherapy before surgery, was initially the standard treatment for patients with locally advanced breast cancer. Currently, it is becoming a commonly used option …
Breast cancer is a heterogeneous disease, and accurate determination of basic biomarkers including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) is crucial for selecting appropriate …
Authors:
Sei Na, Milim Kim, Yujun Park, Hyun Jung Kwon, Hee-Chul Shin, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, So Yeon Park
Open Access
20-04-2024 | Breast Cancer | Original Article
Despite substantial advances in therapy, advanced breast cancer (ABC) remains an incurable disease with a 5-year survival rate of ~ 25% [ 1 ]. Of the different disease subtypes, hormone receptor-positive (HR+)/human epidermal growth factor receptor …
